Shreyaansh Lifesciences, Jaipur. India

faricimab-svoa injection
faricimab-svoa is a vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2) inhibitor indicated for the treatment of patients with Neovascular (wet) Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME).

Get Access To faricimab-svoa injection

Ribociclib-tablets Available Price In India UK Saudi Arabia

faricimab-svoa injection Tablets

  • API – faricimab-svoa injection, for intravitreal use
  • Packaging – injection
  • Strength – Injection: 120 mg/mL solution in a single-dose vial 
  • Manufacturer Name – Genentech

What is faricimab-svoa used for?

Faricimab is a monoclonal antibody used for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).Faricimab is the first bispecific monoclonal antibody, to target both vascular endothelial growth factor (VEGF), and angiopoietin 2 (Ang-2) inhibitor. By targeting these pathways, faricimab stabilizes blood vessels in the retina. It is given by intravitreal injection by an ophthalmologist.

Faricimab was developed by Roche. Faricimab was approved for medical use in the United States in January 2022 and in the European Union in September 2022.

    Disclaimer

    All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.